CASI Pharmaceuticals, Inc. 4
4 · CASI Pharmaceuticals, Inc. · Filed Apr 5, 2017
Insider Transaction Report
Form 4
Zukiwski Alexander A
Chief Medical Officer
Transactions
- Award
Stock Options (Right to Buy)
2017-04-03+300,000→ 300,000 totalExercise: $1.34Exp: 2027-04-03→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The stock options vest as follows: 25% following 90 days from the date of grant, and the remainder ratably over three years on a monthly basis.